Skip to content
Search

Latest Stories

Submit Guest Post

UK finance regulator to simplify London listing rules

The FCA stated that it “proposes to reform and streamline the listing rules in the UK to help attract a broader range of companies, encourage competition, and improve choice for investors.”

Britain's finance regulator unveiled plans to ease London stock exchange flotation regulations, in the face of stiff competition from New York.

In a statement issued on Tuesday (2), the Financial Conduct Authority (FCA) stated that it "proposes to reform and streamline the listing rules in the UK to help attract a broader range of companies, encourage competition, and improve choice for investors."


The news comes as London's top-tier FTSE 100 stock index fights to remain a worldwide influence following Brexit.

London has already lost its crown as the top European trading hub following Britain's departure from the European Union in early 2021, despite earlier post-Brexit reforms.

The FCA said Tuesday that some issuers and advisers regarded rules for UK listings as "too complicated and onerous".

The watchdog proposes "significant changes" to the rulebook, including replacing standard and premium listing segments with one single category for equity shares in commercial firms.

"The proposed changes aim to provide a simpler and more accessible UK listing regime for companies, improving the attractiveness of listing in the UK and providing a wider range of investment opportunities for investors," it said.

Tuesday's news comes after the London stock market took a heavy knock in March after UK-based Arm, a giant of semiconductor design, chose New York for an initial public offering.

That announcement came hot on the heels of news that building materials giant CRH would switch its primary market listing to New York from London.

"London is a major international market with a deservedly good reputation globally among companies aiming to raise capital," added FCA chief executive Nikhil Rathi.

"Our proposed reforms would significantly rebalance the burden of regulation to the benefit of listed companies and investors."

The FCA will consult with interested parties on the proposals until June, before publishing new IPO rules in late 2023 or early 2024.

(AFP)

Add EasternEye As Your Trusted Source
preferred source on google news

More For You

AstraZeneca

AstraZeneca chief executive Pascal Soriot says the company has the science, pipeline and team to deliver its long-term growth ambitions

Getty Images

AstraZeneca targets $80bn revenue by 2030 with $1.5bn savings and pipeline investment

  • AstraZeneca expects its restructuring programme to generate $1.5bn in annualised savings by 2029, with most of the money reinvested in research and development.
  • The plan could incur up to $2bn in one-off restructuring costs, although the company expects its overall workforce to continue growing.
  • Third-quarter revenue rose 7 per cent to $16.21bn, while oncology sales increased 17 per cent to $7.77bn.

AstraZeneca has unveiled plans to generate around $1.5bn in annual savings through a three-year restructuring programme, as chief executive Pascal Soriot shifts the focus back to growth and investment in its drug pipeline.

The British-based pharmaceutical group said its Reshaping for Sustainable Growth programme would redirect resources towards research and development, particularly its pipeline of more than 180 projects and emerging technologies.

Keep ReadingShow less